Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis.

Cell Reports
Chen-Ju LinJerry Pelletier

Abstract

The energetically demanding process of translation is linked to multiple signaling events through mTOR-mediated regulation of eukaryotic initiation factor (eIF)4F complex assembly. Disrupting mTOR constraints on eIF4F activity can be oncogenic and alter chemotherapy response, making eIF4F an attractive antineoplastic target. Here, we combine a newly developed inducible RNAi platform and pharmacological targeting of eIF4F activity to define a critical role for endogenous eIF4F in Myc-dependent tumor initiation. We find elevated Myc levels are associated with deregulated eIF4F activity in the prelymphomatous stage of the Eμ-Myc lymphoma model. Inhibition of eIF4F is synthetic lethal with elevated Myc in premalignant pre-B/B cells resulting in reduced numbers of cycling pre-B/B cells and delayed tumor onset. At the organismal level, eIF4F suppression affected a subset of normal regenerating cells, but this was well tolerated and rapidly and completely reversible. Therefore, eIF4F is a key Myc client that represents a tumor-specific vulnerability.

References

Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·D RousseauN Sonenberg
Jul 5, 2001·Molecular and Cellular Biology·W K MiskiminsR Miskimins
Mar 15, 2002·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Clemens A Schmitt, Scott W Lowe
Dec 12, 2003·Nature·Joseph T OpfermanStanley J Korsmeyer
Mar 19, 2004·Nature·Hans-Guido WendelScott W Lowe
Jan 10, 2006·Genesis : the Journal of Genetics and Development·Caroline BeardRudolf Jaenisch
Jan 17, 2007·Nature Reviews. Microbiology·Laurent BalvayThéophile Ohlmann
Sep 6, 2007·The Journal of Clinical Investigation·Jeremy R GraffEric G Marcusson
Dec 7, 2007·Genes & Development·Hans-Guido WendelScott W Lowe
Mar 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Katrina PodsypaninaHarold E Varmus
Jun 14, 2008·The Journal of Clinical Investigation·Marie-Eve BordeleauJerry Pelletier
Jul 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·John R MillsJerry Pelletier
Mar 25, 2010·Nature Reviews. Cancer·Jan van RiggelenDean W Felsher
Jan 12, 2011·Biochemical Pharmacology·Tomoyuki TsumurayaNaoki Mori
Apr 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Katherine McJunkinScott W Lowe
Aug 31, 2011·Proceedings of the National Academy of Sciences of the United States of America·Nina IlicThomas M Roberts
Sep 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jennifer A MertzRobert J Sims

❮ Previous
Next ❯

Citations

Nov 14, 2013·BMC Pharmacology & Toxicology·Zeina NasrJerry Pelletier
Jun 28, 2013·Proceedings of the National Academy of Sciences of the United States of America·Michael PourdehnadDavide Ruggero
Nov 14, 2014·Open Biology·Becky Pinjou TsaiMarian L Waterman
Dec 6, 2014·Trends in Cell Biology·Elmar WolfDavid L Levens
Dec 25, 2013·Nature Cell Biology·Christof Fellmann, Scott W Lowe
Jan 19, 2016·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Cheryl M KohErnesto Guccione
Jun 24, 2016·Translation·Regina Cencic, Jerry Pelletier
Mar 15, 2016·Oncogene·T LeeJ Pelletier
Mar 22, 2014·International Journal of Cancer. Journal International Du Cancer·Roberta ZappasodiMassimo Di Nicola
Sep 4, 2015·Nature·Tiffany Y-T HsuThomas F Westbrook
Feb 7, 2013·Biochimica Et Biophysica Acta·Regina Cencic, Jerry Pelletier
Mar 7, 2015·Nature Reviews. Drug Discovery·Mamatha BhatIvan Topisirovic
Jun 18, 2016·Frontiers in Oncology·Markus Hartl
Jun 28, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Muhammad Umar AliCao Jiang
Feb 22, 2018·Proceedings of the National Academy of Sciences of the United States of America·David LanglaisPhilippe Gros
Jan 3, 2018·The Journal of Pathology·Amal M El-Naggar, Poul H Sorensen
Feb 15, 2018·Cold Spring Harbor Perspectives in Biology·Jennifer Chu, Jerry Pelletier
Oct 31, 2018·Nature Medicine·Michaël CerezoCaroline Robert
Mar 10, 2018·G3 : Genes - Genomes - Genetics·Alexandra KatigbakJerry Pelletier
Jul 3, 2019·Nature Cell Biology·Feven TameireConstantinos Koumenis
Aug 17, 2019·Learning & Memory·Ilona R Kats, Eric Klann
Feb 6, 2020·RNA·Sai Kiran NaineniJerry Pelletier
Dec 23, 2016·Cellular and Molecular Life Sciences : CMLS·Jutta SteinbergerJerry Pelletier
Feb 6, 2020·International Journal of Molecular Sciences·Eleonora VecchioIleana Quinto
Jun 25, 2020·International Journal of Molecular Sciences·Leo Shen, Jerry Pelletier
Nov 22, 2018·Frontiers in Genetics·Sonali UttamArkady Khoutorsky
Jun 22, 2019·Annual Review of Biochemistry·Jerry Pelletier, Nahum Sonenberg
Jan 11, 2019·Disease Models & Mechanisms·Channabasavaiah B Gurumurthy, Kevin C Kent Lloyd
Sep 15, 2020·Exploration of Targeted Anti-tumor Therapy·Joe TaylorGraham Packham
Sep 19, 2015·Cancer Discovery·Zachary E StineChi V Dang
Dec 17, 2014·Cancer Discovery·Maria M MartinsSourav Bandyopadhyay
Jan 17, 2015·Cancer Research·Jerry PelletierNahum Sonenberg
Jan 7, 2021·The Journal of Cell Biology·Mai SatoJean Gautier

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis